Clinical Topics & News
News
Thirty years of epilepsy therapy: ‘Plus ça change, plus c’est la même chose’?
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...
News
Shift in child hospice care is a lifeline for parents seeking a measure of comfort and hope
Under a provision of the 2010 Affordable Care Act, children enrolled in Medicaid or the Children’s Health Insurance...
News
Managing simple febrile seizures without lumbar puncture safe: 15-year study
Researchers studied evaluation and management before and after AAP’s 2011 simple febrile seizure guidelines and found that limiting diagnostic...
News
FDA OKs IV Briviact for seizures in kids as young as 1 month
The approval marks the first time that the IV formulation will be available for children.
Literature Review
Neurologic drug prices jump 50% in five years
Most of the increased cost was due to rising costs for neuroimmunology drugs, mainly for those used to treat multiple sclerosis (MS).
News
Physicians react: Doctors worry about patients reading their clinical notes
As part of the 21st Century Cures Act, patients will now have the right to see their medical notes.
News
FDA approves cannabidiol for tuberous sclerosis complex
The agency approved the drug for patients 1 year of age and older.
News
FDA approves new treatment for Dravet syndrome
Children treated with fenfluramine experienced significantly greater reductions in the frequency of convulsive seizures than did their peers who...
News
Neurologists’ pay gets a boost, most happy with career choice
Neurologists’ average annual income this year rose to $280,000, up from $267,000 last year.
News
Are patients with epilepsy at increased risk of COVID-19 infection?
The COVID risk may not be elevated, but vigilance and caution are still warranted.